We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $9.16B
1-Year Est. Return 63.5%
This Fund
S&P 500
This Quarter Est. Return
+9.98%
1 Year Est. Return
+63.5%
3 Year Est. Return
+138.65%
5 Year Est. Return
+164.85%
10 Year Est. Return
+779.36%
AUM
$4.99B
AUM Growth
+$345M
Cap. Flow
+$18.7M
Cap. Flow %
0.38%
Top 10 Hldgs %
18.61%
Holding
657
New
20
Increased
200
Reduced
360
Closed
22

Top Sells

Rank Stock Value
1
VAL
Valspar
VAL
+$21.9M
2
PLCM
POLYCOM INC
PLCM
+$12.1M
3
AVT icon
Avnet
AVT
+$9.62M
4
EMC
EMC CORPORATION
EMC
+$7.98M
5
CMI icon
Cummins
CMI
+$7.56M

Sector Composition

Rank Sector Weight
1 Technology 21.54%
2 Communication Services 17.55%
3 Healthcare 14.9%
4 Industrials 10.57%
5 Consumer Discretionary 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLIT icon
51
Harmonic Inc
HLIT
$1.27B
$27.6M 0.55%
4,660,468
-137,022
-3% -$547K
JNJ icon
52
Johnson & Johnson
JNJ
$644B
$27.3M 0.55%
231,360
+5,573
+2% +$676K
AVT icon
53
Avnet
AVT
$7.6B
$26.9M 0.54%
655,913
-235,985
-26% -$9.62M
PFE icon
54
Pfizer
PFE
$157B
$26.7M 0.54%
830,610
+4,462
+0.5% +$149K
T icon
55
AT&T
T
$183B
$26.3M 0.53%
856,285
-636
-0.1% -$20.1K
GPRO icon
56
GoPro
GPRO
$272M
$25.8M 0.52%
+1,548,920
New +$21.3M
PRTA icon
57
Prothena Corp
PRTA
$428M
$25.8M 0.52%
429,922
-6,495
-1% -$348K
V icon
58
Visa
V
$701B
$25.5M 0.51%
308,501
-6,868
-2% -$550K
VEA icon
59
Vanguard FTSE Developed Markets ETF
VEA
$234B
$25.3M 0.51%
675,800
-18,349
-3% -$675K
GILD icon
60
Gilead Sciences
GILD
$181B
$25M 0.5%
316,573
+15,137
+5% +$1.23M
MDY icon
61
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.9B
$25M 0.5%
88,545
-1
-0% -$282
UFI icon
62
UNIFI
UFI
$125M
$24.9M 0.5%
846,279
-19,494
-2% -$531K
CVS icon
63
CVS Health
CVS
$121B
$24.2M 0.48%
271,681
-3,963
-1% -$374K
AMCC
64
DELISTED
Applied Micro Circuits Corporation New
AMCC
$24.2M 0.48%
3,476,738
-32,360
-0.9% -$224K
PG icon
65
Procter & Gamble
PG
$341B
$23.6M 0.47%
262,657
-11,793
-4% -$1.02M
HD icon
66
Home Depot
HD
$305B
$23M 0.46%
178,613
-5,266
-3% -$702K
ARRY
67
DELISTED
Array Biopharma Inc
ARRY
$22.9M 0.46%
3,394,817
-99,310
-3% -$384K
VEU icon
68
Vanguard FTSE All-World ex-US ETF
VEU
$69.1B
$21.9M 0.44%
483,003
-9,588
-2% -$429K
VSH icon
69
Vishay Intertechnology
VSH
$4.82B
$21.8M 0.44%
1,546,239
-33,740
-2% -$454K
INTC icon
70
Intel
INTC
$513B
$21.8M 0.44%
576,225
-3,041
-0.5% -$108K
CCJ icon
71
Cameco
CCJ
$39.7B
$21.5M 0.43%
2,510,901
-64,375
-2% -$619K
GCI
72
DELISTED
Gannett Co., Inc
GCI
$21.3M 0.43%
1,831,161
-27,790
-1% -$346K
MGNX icon
73
MacroGenics
MGNX
$257M
$20.9M 0.42%
698,140
-14,320
-2% -$426K
AGN
74
DELISTED
Allergan plc
AGN
$20.8M 0.42%
90,309
+2,442
+3% +$597K
PARA
75
DELISTED
Paramount Global Class B
PARA
$20.7M 0.42%
378,953
+29,135
+8% +$1.55M

Similar funds

Pinnacle Associates's Q3 2016 Portfolio in Review

As of Q3 2016, Pinnacle Associates held 657 positions worth $4.99B, up 7.4% from $4.64B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Pinnacle Associates's Q3 2016 filing shows 20 new, 200 increased, 360 reduced and 22 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,984,630 shares worth $29.5M. The largest sale was Valspar, an estimated $21.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

  • Pinnacle Associates's largest Q3 2016 buy was Fitbit, Inc. Class A common stock: 1,984,630 shares worth $29.5M.
  • Pinnacle Associates added most to Lazard in Q3 2016, an estimated $17.9M increase.
  • Pinnacle Associates's biggest Q3 2016 reduction was Valspar, cutting an estimated $21.9M.
  • Pinnacle Associates fully exited POLYCOM INC in Q3 2016, selling an estimated $12.1M.
  • Pinnacle Associates's ten largest holdings make up 19% of its $4.99B portfolio in Q3 2016.
  • Pinnacle Associates opened 20 new positions and closed 22 in Q3 2016.
  • Pinnacle Associates's portfolio value rose 7.4% quarter-over-quarter to $4.99B.

Based on Pinnacle Associates's 13F filing for Q3 2016, filed 14 Nov 2016.